Literature DB >> 15776435

Gene conversion between functional trypsinogen genes PRSS1 and PRSS2 associated with chronic pancreatitis in a six-year-old girl.

Niels Teich1, Zsófia Nemoda, Henrik Köhler, Wolfram Heinritz, Joachim Mössner, Volker Keim, Miklós Sahin-Tóth.   

Abstract

Gene conversion--the substitution of genetic material from another gene--is recognized as the underlying cause of a growing number of genetic diseases. While in most cases conversion takes place between a normal gene and its pseudogene, here we report an occurrence of disease-associated gene conversion between two functional genes. Chronic pancreatitis in childhood is frequently associated with mutations of the cationic trypsinogen gene (serine protease 1; PRSS1). We have analyzed PRSS1 in 1106 patients with chronic pancreatitis, and identified a novel conversion event affecting exon 2 and the subsequent intron. The recombination replaced at least 289 nucleotides with the paralogous sequence from the anionic trypsinogen gene (serine protease 2; PRSS2), and resulted in the PRSS1 mutations c.86A > T and c.161A > G, causing the amino acid substitutions N29I and N54S, respectively. Analysis of the recombinant N29I-N54S double mutant cationic trypsinogen revealed increased autocatalytic activation, which was solely due to the N29I mutation. In conclusion, we have demonstrated that gene conversion between two functional paralogous trypsinogen genes can occur and cause genetically determined chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15776435      PMCID: PMC2752332          DOI: 10.1002/humu.20148

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  24 in total

1.  Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen.

Authors:  M Sahin-Tóth; M Tóth
Journal:  Biochem Biophys Res Commun       Date:  2000-11-19       Impact factor: 3.575

2.  Mutations in SBDS are associated with Shwachman-Diamond syndrome.

Authors:  Graeme R B Boocock; Jodi A Morrison; Maja Popovic; Nicole Richards; Lynda Ellis; Peter R Durie; Johanna M Rommens
Journal:  Nat Genet       Date:  2002-12-23       Impact factor: 38.330

Review 3.  Comparative analyses of immunoglobulin genes: surprises and portents.

Authors:  Martin F Flajnik
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

4.  Comparative in vitro studies on native and recombinant human cationic trypsins. Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis.

Authors:  L Szilágyi; E Kénesi; G Katona; G Kaslik; G Juhász; L Gráf
Journal:  J Biol Chem       Date:  2001-04-18       Impact factor: 5.157

5.  Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases.

Authors:  Zoltán Kukor; Miklós Tóth; Miklós Sahin-Tóth
Journal:  Eur J Biochem       Date:  2003-05

6.  Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants.

Authors:  Niels Teich; Nadine Bauer; Joachim Mössner; Volker Keim
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

Review 7.  Gene conversion-like missense mutations in the human cationic trypsinogen gene and insights into the molecular evolution of the human trypsinogen family.

Authors:  J M Chen; C Ferec
Journal:  Mol Genet Metab       Date:  2000-11       Impact factor: 4.797

Review 8.  Molecular pathology and evolutionary and physiological implications of pancreatitis-associated cationic trypsinogen mutations.

Authors:  J M Chen; T Montier; C Férec
Journal:  Hum Genet       Date:  2001-09       Impact factor: 4.132

9.  Evolution of trypsinogen activation peptides.

Authors:  Jian-Min Chen; Zoltán Kukor; Cédric Le Maréchal; Miklós Tóth; Laurent Tsakiris; Odile Raguénès; Claude Férec; Miklós Sahin-Tóth
Journal:  Mol Biol Evol       Date:  2003-06-27       Impact factor: 16.240

10.  Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).

Authors:  Niels Teich; Cédric Le Maréchal; Zoltán Kukor; Karel Caca; Helmut Witzigmann; Jian-Min Chen; Miklós Tóth; Joachim Mössner; Volker Keim; Claude Férec; Miklós Sahin-Tóth
Journal:  Hum Mutat       Date:  2004-01       Impact factor: 4.878

View more
  17 in total

1.  Uncertainties in the classification of human cationic trypsinogen (PRSS1) variants as hereditary pancreatitis-associated mutations.

Authors:  Richárd Szmola; Miklós Sahin-Tóth
Journal:  J Med Genet       Date:  2010-05       Impact factor: 6.318

Review 2.  Biochemical models of hereditary pancreatitis.

Authors:  Miklós Sahin-Tóth
Journal:  Endocrinol Metab Clin North Am       Date:  2006-06       Impact factor: 4.741

3.  Strong purifying selection against gene conversions in the trypsin genes of primates.

Authors:  Nicholas Petronella; Guy Drouin
Journal:  Hum Genet       Date:  2012-06-30       Impact factor: 4.132

Review 4.  Hereditary pancreatic cancer.

Authors:  Shilpa Grover; Sapna Syngal
Journal:  Gastroenterology       Date:  2010-08-19       Impact factor: 22.682

5.  Intragenic duplication: a novel mutational mechanism in hereditary pancreatitis.

Authors:  Maiken T Joergensen; Andrea Geisz; Klaus Brusgaard; Ove B Schaffalitzky de Muckadell; Péter Hegyi; Anne-Marie Gerdes; Miklós Sahin-Tóth
Journal:  Pancreas       Date:  2011-05       Impact factor: 3.327

6.  Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C.

Authors:  András Szabó; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

Review 7.  Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis.

Authors:  Niels Teich; Jonas Rosendahl; Miklós Tóth; Joachim Mössner; Miklós Sahin-Tóth
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

Review 8.  Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis.

Authors:  Balázs Csaba Németh; Miklós Sahin-Tóth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-23       Impact factor: 4.052

Review 9.  Pancreatic cancer screening.

Authors:  Eun Ji Shin; Marcia Irene Canto
Journal:  Gastroenterol Clin North Am       Date:  2012-01-05       Impact factor: 3.806

10.  [Clinical implications of genetic risk factors of chronic pancreatitis].

Authors:  N Teich; V Keim; J Mössner
Journal:  Internist (Berl)       Date:  2005-02       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.